Abbott inks collabs to bring CGM tech to Type 2 diabetes – Fierce Biotech

Weightloss News
Boehringer’s new data drop shows 19% weight loss for phase 2 obesity … Story. June 13 – Encoded Therapeutics: GV-backed gene therapy maker …